Author:
Torres-Valdés Selene Sharid,Carrillo-Torres Orlando,Rascón-Martínez Dulce M
Subject
Anesthesiology and Pain Medicine
Reference47 articles.
1. Neira RF, Ortega GJL. La ketamina en el tratamiento del dolor crónico según medicina basada en la evidencia. Rev SocEsp Dolor. 2016;23:292-306.
2. Chebini A, Marzoughi S, Randhawa J, Guh D, Wiseman S, Fedoroff I, et al. The effects of a multiday (10-14 days) subanesthetic dose IV ketamine infusion in the treatment of refractory chronic pain. Pain Manag. 2022;12:337-346.
3. Kohtala S. Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms. Pharmacol Rep. 2021;73:323-345.
4. Cáñez-Jiménez C, González-López N, Ramírez-Segura EH. Ketamina: adyuvante en el tratamiento del dolor de difícil control. 7a Reunión Interinstitucional de Residentes de Anestesiología. Rev Mex Anest. 2018;41:S153-154.
5. Cohen SP, Bhatia A, Buvanendran A, Schwenk ES, Wasan AD, Hurley RW, et al. Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Vol. 43, Regional Anesthesia and Pain Medicine. Lippincott Williams and Wilkins; 2018. p. 521-546.